Cyteir Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Cyteir Therapeutics

10/08/2021 01:39

* Cyteir Therapeutics Inc  CYT.OQ  reported a quarterly adjusted
loss of $4.83​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of $1.46 per share.
* Reported revenue was zero​;  analysts expected zero. 
* Cyteir Therapeutics Inc's reported EPS for the quarter was a
loss of $4.83​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Cyteir Therapeutics Inc shares had fallen by 8.7% this
quarter.
* The company reported a quarterly loss of $11.3 million.
* Wall Street's median 12-month price target for Cyteir
Therapeutics Inc is $31.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 10 at 12:39 a.m.  ​All
figures in US dollars unless otherwise stated